Ledger.Open graph →
SEC Form D · Amendment · filed June 20, 2019

RAPT Therapeutics, Inc

Offering
$67.1M
Sold
$37.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Dirk F. Brockstedt · South San Francisco, CAExecMichael F. Giordano · South San Francisco, CADirectorWilliam F. Ho · South San Francisco, CAExecBrian Wong · South San Francisco, CAExec · DirectorLinda J. Kozick · South San Francisco, CADirectorWilliam J. Rieflin · South San Francisco, CADirectorDavid V. Goeddel · South San Francisco, CADirectorBeth V. Seidenberg · South San Francisco, CADirectorJoshua Malouf · Goleta, CAExecChristopher Savoie · Boston, MADirectorClark Golestani · Boston, MAExec · DirectorGuilherme Peres · Goleta, CADirectorMark Cupta · Boston, MADirectorEmily Hanson · Goleta, CAExecDavid F. Wustrow · South San Francisco, CAExecPaul F. Kassner · South San Francisco, CAExecEric F. Hall · South San Francisco, CAExecMichael D'Angelo · Tucson, AZExecTerry Esser · Tucson, AZExecJennifer Henderson · Fort Collins, CODirectorMichael B. Lazar · Greenwich, CTDirectorFranklin J. Collins Iv · Greenwich, CTDirectorNasrin Thierer · Chicago, ILExec · DirectorDavid F. Wustrow · South San Francisco, CAExecPaul F. Kassner · South San Francisco, CAExecEric F. Hall · South San Francisco, CAExecDavid V. Goeddel · South San Francisco, CADirectorBeth V. Seidenberg · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗